幹細胞治療の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Stem Cell Therapy Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: Understanding of stem cell therapy
• History of stem cell research

PART 06: Ethical issues and regulatory landscape
• Ethical issues of stem cell research at different phases of research

PART 07: Key clinical trials
• Attractive clinical trial locations to invest
• Commercially attractive therapy areas to invest

PART 08: Market landscape
• Market overview
• Five forces analysis

PART 09: Market segmentation by therapy
• Allogeneic stem cell therapy
• Autologous stem cell therapy

PART 10: Market segmentation by applications
• Dermatology
• Musculoskeletal
• Cardiovascular

PART 11: Geographical segmentation
• Stem cell therapy market in Americas
• Stem cell therapy market in EMEA
• Stem cell therapy market in APAC

PART 12: Market drivers
• Limitations in traditional organ transplantations fueling the demand for stem cell therapies
• Increase in federal funding in stem cell therapy
• Growing demand for personalized medicine
• Increasing demand to develop effective drugs for cardiology and degenerative disorders

PART 13: Impact of drivers

PART 14: Market challenges
• Stringent regulatory environment affecting the product approvals
• Critical ethical challenges with respect to stem cell research
• High cost of clinical trials and failure rate in clinical trials

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Evolution of new destinations in the development of stem cell therapies
• Increasing inorganic growth strategies such as acquisitions and licensing agreements
• Growing focus on the development of drugs for emerging applications
• Increasing investments from private enterprises likely to fuel market growth

PART 17: Vendor landscape
• Competitive scenario

PART 18: Key vendor analysis
• Holostem Advanced Therapies
• JCR Pharmaceuticals
• Organogenesis
• Osiris Therapeutics
• Vericel1
• Other prominent vendors4

PART 19: Appendix7
• List of abbreviations7

PART 20: Explore Technavio9

[List of Exhibits]

Exhibit 01: Developments in stem cell research
Exhibit 02: Ethical issues faced by various institutes at different phases of cell therapy research
Exhibit 03: Stem cell research policies in Americas
Exhibit 04: Stem cell research policies in EMEA
Exhibit 05: Stem cell research policies in APAC
Exhibit 06: Historical trend of pipeline candidates in different phases
Exhibit 07: Snapshot of pipeline trends in stem cell therapy market
Exhibit 08: Pipeline landscape by therapeutic area 2016
Exhibit 09: Pipeline by development phase 2016
Exhibit 10: Pipeline snapshot in key therapy areas
Exhibit 11: Brief overview of attractive clinical trial locations, therapy areas, and cell types
Exhibit 12: Key clinical trials
Exhibit 13: Global stem cell therapy market snapshot
Exhibit 14: Key marketed products and their company
Exhibit 15: Key vendors with robust Phase III pipeline
Exhibit 16: Global stem cell therapy market 2016-2021 ($ millions)
Exhibit 17: Opportunity analysis in global stem cell therapy market
Exhibit 18: Five forces analysis
Exhibit 19: Global stem cell therapy market segmentation by therapy 2016
Exhibit 20: Global allogeneic stem cell therapy market 2016-2021 ($ millions)
Exhibit 21: Opportunity analysis of allogeneic stem cell therapy market
Exhibit 22: Global autologous stem cell therapy market 2016-2021 ($ millions)
Exhibit 23: Opportunity analysis of autologous stem cell therapy market
Exhibit 24: Global stem cell therapy market segmentation by application 2016
Exhibit 25: Overview of dermatology in stem cell therapy market
Exhibit 26: Overview of musculoskeletal in regenerative medicine market
Exhibit 27: Overview of cardiovascular in stem cell therapy market
Exhibit 28: Segmentation of global stem cell therapy market based on geography 2016 and 2021
Exhibit 29: Stem cell therapy market revenue by geography 2016-2021 ($ millions)
Exhibit 30: Market scenario in Americas
Exhibit 31: Stem cell therapy market in Americas ($ millions)
Exhibit 32: Market scenario in EMEA
Exhibit 33: Stem cell therapy market in EMEA ($ millions)
Exhibit 34: Market scenario in APAC
Exhibit 35: Stem cell therapy market in APAC ($ millions)
Exhibit 36: Key stem cell therapy market developments in Japan by global vendors 2015
Exhibit 37: NIH: YoY and growth rate of spending toward stem cell research ($ billions)
Exhibit 38: Breakdown of CIRM funding in various stem cell research funding in 2014 ($ billions)
Exhibit 39: Active programs under CIRM 2014
Exhibit 40: Details of EC funding
Exhibit 41: Impact of drivers
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Regulatory guidelines in Japan
Exhibit 44: Key inorganic growth strategies in global stem cell therapy market
Exhibit 45: Competitive structure analysis of global stem cell therapy market 2016
Exhibit 46: Competitive analysis of global stem cell therapy market
Exhibit 47: Some of the key approvals in global stem cell therapy
Exhibit 48: Strategic success factors of companies in global stem cell therapy market
Exhibit 49: Holostem Advanced Therapies: Key highlights
Exhibit 50: Holostem Advanced Therapies: Strength assessment
Exhibit 51: Holostem Advanced Therapies: Strategy assessment
Exhibit 52: Holostem Advanced Therapies: Opportunity assessment
Exhibit 53: JCR Pharmaceuticals: Strength assessment
Exhibit 54: JCR Pharmaceuticals: Strategy assessment
Exhibit 55: JCR Pharmaceuticals: Opportunity assessment
Exhibit 56: Organogenesis: Key highlights
Exhibit 57: Organogenesis: Strength assessment
Exhibit 58: Organogenesis: Strategy assessment
Exhibit 59: Organogenesis: Opportunity assessment
Exhibit 60: Osiris Therapeutics: Key highlights
Exhibit 61: Osiris Therapeutics: Strength assessment
Exhibit 62: Osiris Therapeutics: Strategy assessment
Exhibit 63: Osiris Therapeutics: Opportunity assessment
Exhibit 64: Vericel: Key highlights
Exhibit 65: Vericel: Strength assessment
Exhibit 66: Vericel: Strategy assessment
Exhibit 67: Vericel: Opportunity assessment


【レポート販売概要】

■ タイトル:幹細胞治療の世界市場2017-2021
■ 英文:Global Stem Cell Therapy Market 2017-2021
■ 発行日:2017年1月25日
■ 調査会社:Technavio
■ 商品コード:IRTNTR11121
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。